XML 139 R4.htm IDEA: XBRL DOCUMENT v3.25.0.1
Statements of Operations and Comprehensive Loss - USD ($)
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Operating expenses:      
Research and development $ 5,908,288 $ 8,976,643 $ 5,919,452
General and administrative 5,898,775 6,505,721 5,941,169
Total operating expenses 11,807,063 15,482,364 11,860,621
Operating loss (11,807,063) (15,482,364) (11,860,621)
Other income (expense), net (219,812) 10,045 (17,323)
Interest expense (119,920) (95,211) (48,100)
Interest on related party loans (25,233) (5,655) (20,034)
Loss on extinguishment of convertible notes (922,495)
Net loss (12,172,029) (16,495,680) (11,946,078)
Other comprehensive loss:      
Defined pension plan adjustments (107,280) 100,948 (132,358)
Comprehensive loss $ (12,279,309) $ (16,394,732) $ (12,078,436)
Basic net loss per common share (in Dollars per share) $ (0.32) $ (0.84) $ (1)
Diluted net loss per common share (in Dollars per share) $ (0.32) $ (0.84) $ (1)
Weighted average common shares used in computing basic net loss per common share (in Shares) 38,176,020 19,682,643 11,901,636
Weighted average common shares used in computing diluted net loss per common share (in Shares) 38,176,020 19,682,643 11,901,636